Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Harmon

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Oncologist|May 25, 1999
A staff dialogue on aggressive palliative treatment demanded by a terminally ill patient: psychosocial issues faced by patients, their families, and caregiversK C Lintz, R T Penson, N Cassem, et al.
Cancer|May 1, 1984
Ewing's sarcoma in female siblings. A clinical report and review of the literatureM J Joyce, D C Harmon, H J Mankin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1984
Lymphocyte surface markers in orbital lymphoid neoplasmsD C Harmon, A C Aisenberg, N L Harris, et al.
Seminars in Oncology|October 31, 1997
Prognostic factors for local control of sarcomas of the soft tissues managed by radiation and surgeryI J Spiro, M C Gebhardt, L C Jennings, et al.
International Journal of Radiation Oncology, Biology, Physics|December 29, 1999
Long-term results of combined modality therapy in primary bone lymphomasP Fidias, I Spiro, M L Sobczak, et al.
Radiology|April 1, 1992
Compositional changes in vertebral bone marrow during treatment for acute leukemia: assessment with quantitative chemical shift imagingE L Gerard, J A Ferry, P C Amrein, et al.
The American Journal of Surgical Pathology|April 1, 1990
Primary lymphoma of bone. A B-cell neoplasm with a high frequency of multilobated cellsC K Pettit, L R Zukerberg, M H Gray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Treatment of the patient with stage M0 soft tissue sarcomaH D Suit, H J Mankin, W C Wood, et al.
Cancer|April 29, 1998
Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group BB L Samuels, J E Herndon, D C Harmon, et al.
Cancer|June 1, 1997
Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group BN J Yogelzang, J E Herndon, C Cirrincione, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Oncologist|May 25, 1999
A staff dialogue on aggressive palliative treatment demanded by a terminally ill patient: psychosocial issues faced by patients, their families, and caregiversK C Lintz, R T Penson, N Cassem, et al.
Cancer|May 1, 1984
Ewing's sarcoma in female siblings. A clinical report and review of the literatureM J Joyce, D C Harmon, H J Mankin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1984
Lymphocyte surface markers in orbital lymphoid neoplasmsD C Harmon, A C Aisenberg, N L Harris, et al.
Seminars in Oncology|October 31, 1997
Prognostic factors for local control of sarcomas of the soft tissues managed by radiation and surgeryI J Spiro, M C Gebhardt, L C Jennings, et al.
International Journal of Radiation Oncology, Biology, Physics|December 29, 1999
Long-term results of combined modality therapy in primary bone lymphomasP Fidias, I Spiro, M L Sobczak, et al.
Radiology|April 1, 1992
Compositional changes in vertebral bone marrow during treatment for acute leukemia: assessment with quantitative chemical shift imagingE L Gerard, J A Ferry, P C Amrein, et al.
The American Journal of Surgical Pathology|April 1, 1990
Primary lymphoma of bone. A B-cell neoplasm with a high frequency of multilobated cellsC K Pettit, L R Zukerberg, M H Gray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Treatment of the patient with stage M0 soft tissue sarcomaH D Suit, H J Mankin, W C Wood, et al.
Cancer|April 29, 1998
Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group BB L Samuels, J E Herndon, D C Harmon, et al.
Cancer|June 1, 1997
Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group BN J Yogelzang, J E Herndon, C Cirrincione, et al.
Pageof 4